Market news: South Korea's ruling party has elected a new party leader, and the new leader said that a presidential election may be held soon.Evergrande Group and others were resumed execution by 320 million yuan. According to the information of legal proceedings, on December 11th, Evergrande Group Co., Ltd. added two pieces of resumption execution information, with a total execution amount of more than 322 million yuan, involving construction project contract disputes. The executors also included Hefei Yuetai Commercial Operation Management Co., Ltd. and Evergrande Real Estate Group Co., Ltd., and the enforcement court was the Baohe District People's Court in Hefei.Wang Xiaochuan Baichuan Intelligent has set up a technology company in Ningbo with a number of AI businesses. According to enterprise investigation, recently, Ningbo Baichuan Ronghui Technology Co., Ltd. was established with Wang Xiaochuan as the legal representative and a registered capital of 70 million US dollars. Its business scope includes artificial intelligence dual-creation service platform, artificial intelligence theory and algorithm software development, artificial intelligence basic software development, artificial intelligence general application system, artificial intelligence public data platform and artificial intelligence public service platform technical consulting service. Equity penetration shows that the company is wholly owned by BAICHUAN AI (HK) LIMITED.
China Seismological Network officially determined that an earthquake of magnitude 5.2 occurred in Fiji Islands (14.95 degrees south latitude and 178.15 degrees west longitude) at 09: 51 on December 12, with a focal depth of 10 kilometers.The liquor sector moved up, Tianyoude Liquor rose daily, Gujing Distillery rose by more than 4%, and Huangtai Liquor, Shunxin Agriculture, Laobaigan Liquor and Yilite followed suit.In the concept of ice and snow economy, there were many daily limit changes, such as iceberg cold and hot, iceberg cold and hot, Longjian shares and Jingxue energy-saving daily limit, and Dalian Shengya, Changbai Mountain, Yeti shares and Sante ropeway were among the top gainers.
Zhejiang has published a list of the top 500 enterprises. According to the news released by Zhejiang in WeChat official account, Zhejiang Institute of Science and Technology Information organized the evaluation of innovation ability of high-tech enterprises, and recently selected the top 500 high-tech enterprises in Zhejiang Province in 2024. Among them, Hangzhou Hikvision Digital Technology Co., Ltd., Ningbo Oaks Electric Co., Ltd. and Xinhua San Technology Co., Ltd. are in the top three.The annual passenger flow at the West Kowloon Station Port exceeded 25 million for the first time. It was learned from the West Kowloon Border Inspection Station of Shenzhen Border Inspection Station that as of 24: 00 on December 11th, the cumulative passenger flow at the West Kowloon Border Inspection Station exceeded 25 million for the first time this year, accounting for 36.7% of the total passenger flow since the opening of the West Kowloon Station Port, an increase of 36.5% compared with last year, an increase of 33% on average daily passenger flow, and 32.5% of foreign passengers entering the country without visas. Inspection ensures that cross-border trains increase by 36% year-on-year, and "customs clearance flow" helps "economic growth", injecting border inspection momentum into the country's high-level open and high-quality development. (Voice of Greater Bay Area)Genting Xinyao: The first prescription of itramod in Macau, China officially benefited Asian patients. Genting Xinyao announced that its first prescription of itramod was made in Jinghu Hospital in Macau, China on December 11th, which was the first prescription made by itramod after it was approved in Genting Xinyao Asia Authorized Zone, marking that this heavy product in the field of autoimmune diseases officially began to benefit Asian patients. Luo Yongqing, CEO of Genting Xinyao, said that the arrival of the first prescription of Ithmod in China and Macau was another milestone in the commercialization of Genting Xinyao. By 2030, the number of patients with ulcerative colitis in China is expected to more than double that in 2019, reaching about 1 million. There is a huge unmet demand for innovative therapies. Following the approval in Macau in April this year, Iturmod, as the third commercial new drug of Genting Xinyao, will bring new treatment options to more patients with ulcerative colitis.
Strategy guide 12-13
Strategy guide
12-13
Strategy guide
12-13